Detalhe da pesquisa
1.
Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.
J Cell Biochem
; 120(10): 18332-18345, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31257681
2.
Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCßII expression in B lymphocytes.
Haematologica
; 100(4): 499-510, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616575
3.
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
Br J Haematol
; 161(4): 578-86, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23496350
4.
PKCß Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling.
Cancers (Basel)
; 14(23)2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497487
5.
AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.
Clin Cancer Res
; 25(5): 1574-1587, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559170
6.
The role of mTOR-mediated signaling in the regulation of cellular migration.
Immunol Lett
; 196: 74-79, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408410
7.
The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation.
Leuk Res
; 35(10): 1279-85, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21722956